SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis

Primary Care Diabetes ◽

10.1016/j.pcd.2018.02.001 ◽

2018 ◽

Vol 12 (3) ◽

pp. 265-283 ◽

Author(s):

Samuel Seidu ◽

Setor K. Kunutsor ◽

Xavier Cos ◽

Syed Gillani ◽

Kamlesh Khunti

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Renal Impairment ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Download Full-text

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Cardiovascular Outcome Trials ◽

Download Full-text

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

10.1016/s0140-6736(18)32590-x ◽

2019 ◽

Vol 393 (10166) ◽

pp. 31-39 ◽

Author(s):

Thomas A Zelniker ◽

Stephen D Wiviott ◽

Itamar Raz ◽

Kyungah Im ◽

Erica L Goodrich ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Cardiovascular Outcome Trials ◽

Download Full-text

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Endocrinology and Metabolism ◽

10.3803/enm.2019.34.1.80 ◽

2019 ◽

Vol 34 (1) ◽

pp. 80 ◽

Author(s):

Jae Hyun Bae ◽

Sunhee Kim ◽

Eun-Gee Park ◽

Sin Gon Kim ◽

Seokyung Hahn ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Renal Outcomes ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

SGLT2 Inhibitors and Stroke Risk in Patients with Type 2 Diabetes—A Systematic Review and Meta-analysis

Diabetes ◽

10.2337/db18-165-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 165-OR

Author(s):

MAN GUO ◽

YONG XU

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Stroke Risk ◽

Meta Analysis ◽

Sglt2 Inhibitors

Download Full-text

2300-PUB: The Efficacy and Safety of Combinations of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: A Systematic Review and Meta-analysis

Diabetes ◽

10.2337/db19-2300-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2300-PUB

Author(s):

MAN GUO ◽

JUNLING GU ◽

JINGSONG LI ◽

YONG XU

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Efficacy And Safety ◽

Receptor Agonists

Download Full-text

SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Value in Health ◽

10.1016/j.jval.2016.03.1311 ◽

2016 ◽

Vol 19 (3) ◽

pp. A197 ◽

Author(s):

C.A. Sevald ◽

J.D. Jackson ◽

J.F. McAna

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Sglt2 Inhibitors

Download Full-text

Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis

Scientific Reports ◽

10.1038/s41598-017-02733-w ◽

2017 ◽

Vol 7 (1) ◽

Author(s):

Jiali Liu ◽

Ling Li ◽

Sheyu Li ◽

Pengli Jia ◽

Ke Deng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Genital Infections

Download Full-text

Effect of dipeptidyl peptidase 4 inhibitors on cardiovascular events in type-2 diabetes patients with renal impairment: A systematic review and meta-analysis

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_568_19 ◽

2020 ◽

Vol 24 (2) ◽

pp. 143

Author(s):

Maneesha Khalse ◽

B Ganapathy

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Renal Impairment ◽

Cardiovascular Events ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: a systematic review and network meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.109146 ◽

2021 ◽

pp. 109146

Author(s):

Yuki Kawai ◽

Kazushi Uneda ◽

Takayuki Yamada ◽

Sho Kinguchi ◽

Kazuo Kobayashi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Renal Outcomes ◽

Receptor Agonists

Download Full-text

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108737 ◽

2021 ◽

Vol 174 ◽

pp. 108737

Author(s):

Thomas Karagiannis ◽

Apostolos Tsapas ◽

Eleni Athanasiadou ◽

Ioannis Avgerinos ◽

Aris Liakos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Older People ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Receptor Agonists

Download Full-text